273 related articles for article (PubMed ID: 20078611)
21. Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.
Bemer MJ; Risler LJ; Phillips BR; Wang J; Storer BE; Sandmaier BM; Duan H; Raccor BS; Boeckh MJ; McCune JS
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1544-52. PubMed ID: 24923537
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic monitoring of mycophenolate mofetil.
Budde K; Glander P; Bauer S; Braun K; Waiser J; Fritsche L; Mai I; Roots I; Neumayer HH
Clin Chem Lab Med; 2000 Nov; 38(11):1213-6. PubMed ID: 11156363
[TBL] [Abstract][Full Text] [Related]
23. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
Staatz CE; Tett SE
Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
[TBL] [Abstract][Full Text] [Related]
24. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
Langman LJ; LeGatt DF; Halloran PF; Yatscoff RW
Transplantation; 1996 Sep; 62(5):666-72. PubMed ID: 8830834
[TBL] [Abstract][Full Text] [Related]
25. Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells.
Glander P; Braun KP; Hambach P; Bauer S; Mai I; Roots I; Waiser J; Fritsche L; Neumayer HH; Budde K
Clin Biochem; 2001 Oct; 34(7):543-9. PubMed ID: 11738390
[TBL] [Abstract][Full Text] [Related]
26. Mycophenolate pharmacokinetics and inosine monophosphate dehydrogenase activity in liver transplant recipients with an emphasis on therapeutic drug monitoring.
Reine PA; Vethe NT; Kongsgaard UE; Andersen AM; Line PD; Ali AM; Bergan S
Scand J Clin Lab Invest; 2013 Mar; 73(2):117-24. PubMed ID: 23281843
[TBL] [Abstract][Full Text] [Related]
27. High interpatient variability in response to mycophenolic acid maintenance therapy in patients with ANCA-associated vasculitis.
Schaier M; Scholl C; Scharpf D; Schmitt WH; Schwenger V; Zeier M; Sommerer C
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i138-45. PubMed ID: 25805745
[TBL] [Abstract][Full Text] [Related]
28. Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphism.
Sombogaard F; van Schaik RH; Mathot RA; Budde K; van der Werf M; Vulto AG; Weimar W; Glander P; Essioux L; van Gelder T
Pharmacogenet Genomics; 2009 Aug; 19(8):626-34. PubMed ID: 19617864
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.
Sommerer C; Müller-Krebs S; Schaier M; Glander P; Budde K; Schwenger V; Mikus G; Zeier M
Br J Clin Pharmacol; 2010 Apr; 69(4):346-57. PubMed ID: 20406219
[TBL] [Abstract][Full Text] [Related]
30. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
Goldsmith D; Carrey EA; Edbury S; Smolenski RT; Jagodzinski P; Simmonds HA
Clin Sci (Lond); 2004 Jul; 107(1):63-8. PubMed ID: 14723604
[TBL] [Abstract][Full Text] [Related]
31. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
Weigel G; Griesmacher A; Zuckermann AO; Laufer G; Mueller MM
Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978
[TBL] [Abstract][Full Text] [Related]
32. Activation of the purine salvage pathway in mononuclear cells of cardiac recipients treated with mycophenolate mofetil.
Devyatko E; Zuckermann A; Bohdjalian A; Roedler S; Dunkler D; Grimm M; Weigel G
Transplantation; 2006 Jul; 82(1):113-8. PubMed ID: 16861950
[TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.
Tang JT; de Winter BC; Hesselink DA; Sombogaard F; Wang LL; van Gelder T
Br J Clin Pharmacol; 2017 Apr; 83(4):812-822. PubMed ID: 27753146
[TBL] [Abstract][Full Text] [Related]
34. No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
Rissling O; Glander P; Hambach P; Mai M; Brakemeier S; Klonower D; Halleck F; Singer E; Schrezenmeier EV; Dürr M; Neumayer HH; Budde K
Br J Clin Pharmacol; 2015 Nov; 80(5):1086-96. PubMed ID: 25913040
[TBL] [Abstract][Full Text] [Related]
35. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
36. Inosine monophosphate dehydrogenase activity and mycophenolate pharmacokinetics in children with nephrotic syndrome treated with mycophenolate mofetil.
Sobiak J; Resztak M; Zachwieja J; Ostalska-Nowicka D
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1197-1208. PubMed ID: 35877984
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolic acid concentrations in peripheral blood mononuclear cells are associated with the incidence of rejection in renal transplant recipients.
Md Dom ZI; Coller JK; Carroll RP; Tuke J; McWhinney BC; Somogyi AA; Sallustio BC
Br J Clin Pharmacol; 2018 Oct; 84(10):2433-2442. PubMed ID: 29974488
[TBL] [Abstract][Full Text] [Related]
38. Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation.
Kagaya H; Miura M; Saito M; Habuchi T; Satoh S
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):631-6. PubMed ID: 20136638
[TBL] [Abstract][Full Text] [Related]
39. Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.
Dong M; Fukuda T; Cox S; de Vries MT; Hooper DK; Goebel J; Vinks AA
Br J Clin Pharmacol; 2014 Nov; 78(5):1102-12. PubMed ID: 24837828
[TBL] [Abstract][Full Text] [Related]
40. Optimization and application of an HPLC method for quantification of inosine-5'-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients.
Liu F; Xu L; Sheng C; Qiu X; Zhang M; Jiao Z
Clin Chim Acta; 2018 Oct; 485():333-339. PubMed ID: 29964005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]